Evidence map›Paper›PMID 38022674›Full record

ArticleFrontiers in immunology2023

Further characterization of

Franklin R Toapanta, Jingping Hu, Shiri Meron-Sudai, Laurence A Mulard, Armelle Phalipon, Dani Cohen, Marcelo B Sztein

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in immunology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.6field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Trial
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 3 countries.

Franklin R ToapantaDepartment of Medicine and Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, MD, United States.
Jingping HuDepartment of Medicine and Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, MD, United States.
Shiri Meron-SudaiSchool of Public Health, Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Laurence A MulardInstitut Pasteur, Université Paris Cité, CNRS UMR3523, Unité Chimie des Biomolécules, Paris, France.
Armelle PhaliponInstitut Pasteur, Université Paris Cité, Laboratoire Innovation: Vaccins, Paris, France.
Dani CohenSchool of Public Health, Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Marcelo B SzteinDepartment of Medicine and Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, MD, United States.
University of Maryland, Baltimore · USTel Aviv University · ILUniversité Paris Cité · FR

Funding

University of Maryland Claude D. Pepper Older Americans Independence Center (UM-OAIC)P30AG028747 · NIA · UNIVERSITY OF MARYLAND BALTIMORE · PI Stephen L. Seliger · 2006 to 2026
$28.9M
Wild-type S. typhi Infection in Humans: Integrated Immunoprotective MechanismsU19AI082655 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI SZTEIN, MARCELO B. · 2009 to 2018
$27.8M
IMMUNE MECHANISMS OF PROTECTION IN S TYPHI VACCINESR01AI036525 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI Marcelo B. Sztein · 1994 to 2026
$12.2M
NIAID NIH HHS R01 AI036525NIAID NIH HHS U19 AI082655NIA NIH HHS P30 AG028747
6 · The paper itself

Abstract

Shigellosis is common worldwide, and it causes significant morbidity and mortality mainly in young children in low- and middle- income countries. To date, there are not broadly available licensed

Indexed as

ShigellaShigella VaccinesChild, PreschoolClinical Trials, Phase I as TopicHealthy VolunteersHumansImmunoglobulin AImmunoglobulin GLipopolysaccharidesMemory B CellsSerogroupShigella flexneriVaccines, SyntheticImmunoglobulin AImmunoglobulin GLipopolysaccharidesShigella VaccinesVaccines, Syntheticantigen-specific B cellsconjugate vaccinememory B cellsShigellasynthetic carbohydrate

Identifiers

PMID38022674
PMCPMC10653583
OpenAlexW4388081612

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.